From Toshiba America Medical Systems Inc.;
OPART™ is a 0.35 T superconducting open MR system featuring cryogenless operation. Superconducting speed and performance are combined with the patient access advantages of open MRI design for unmatched clinical versatility. OPART™ features innovative technologies such as digital RF, high speed gradients and optimized RF coils, which support advanced MRI applications.

Omniscan® is a nonionic chelate complex with low osmolality used as a paramagnetic MRI contrast agent. The efficacy of Omniscan® is similar to that of Gd-DTPA. Omniscan® is given intravenously to enhance images of intracranial and spinal lesions where there is abnormal vascularity or an abnormal blood brain barrier. The complex does not cross an intact blood brain barrier so Omniscan® only accumulates in lesions such as neoplasm's and abscesses.

WARNING: NEPHROGENIC SYSTEMIC FIBROSIS Gadolinium-based contrast agents increase the risk for nephrogenic systemic fibrosis (NSF) in patients with acute or chronic severe renal insufficiency (glomerular filtration rate less than 30 mL/min/1.73m²), or acute renal insufficiency of any severity due to the hepato-renal syndrome or in the perioperative liver transplantation period.

See also Gadodiamide, and Classifications, Characteristics, etc.

Manufactured by Esaote S.p.A.;
a low field open MRI scanner with permanent magnet for orthopedic use. The outstanding feature of this MRI system is a patient friendly design with 24 cm diameter, which allows the imaging of extremities and small body parts like shoulder MRI. The power consumption is around 1.3 kW and the needed minimum floor space is an area of 16 sq m.
At RSNA 2006 Hologic Inc. introduced a new dedicated extremity MRI scanner, the Opera. Manufactured by Esaote is the Opera a redesign of Esaote's 0.2 Tesla E-Scan XQ platform, which now enables complete imaging of all extremities, including hip and shoulder applications. 'Real-time positioning' reportedly speeds patient setup and reduces exam times.
Esaote North America and Hologic Inc are the U.S. distributors of this MRI device.

From Philips Medical Systems;
the Panorama 0.23 T, providing a new design optimized for patient comfort, faster reconstruction time than before (300 images/second) and new gradient specifications. Philips' Panorama 0.23 T I/T supports MR-guided interventions, resulting in minimally invasive procedures, more targeted surgery, reduced recovery time and shorter hospital stays. Optional OptoGuide functionality enables real-time needle tracking. Philips' Panorama 0.23 TPanorama 0.2 R/T is the first and only open MRI system to enable radiation therapy planning using MR data sets. The Panorama also features the new and consistent Philips User Interface, an essential element of the Vequion clinical IT family of products and services.

(PC) Phase contrast sequences are the basis of MRA techniques utilizing the change in the phase shifts of the flowing protons in the region of interest to create an image. Spins that are moving along the direction of a magnetic field gradient receive a phase shift proportional to their velocity.
In a phase contrast sequence two data sets with a different amount of flow sensitivity are acquired. This is usually accomplished by applying gradient pairs, which sequentially dephase and then rephase spins during the sequence. Both 2D and 3D acquisition techniques can be applied with phase contrast MRA.
The first data set is acquired with a flow compensated sequence, i. e. without flow sensitivity. The second data set is acquired with a flow sensitive sequence. The amount of flow sensitivity is controlled by the strength of the bipolar gradient pulse pair, which is incorporated into the sequence. Stationary tissue undergoes no effective phase change after the application of the two gradients. Caused by the different spatial localization of flowing blood to stationary tissue, it experiences a different size of the second bipolar gradient compared to the first. The result is a phase shift.
The raw data from the two data sets are subtracted. By comparing the phase of signals from each location in the two sequences the exact amount of motion induced phase change can be determined to have a map where pixel brightness is proportional to spatial velocity.
Phase contrast images represent the signal intensity of the velocity of spins at each point within the field of view. Regions that are stationary remain black while moving regions are represented as grey to white.
The phase shift is proportional to the spin's velocity, and this allows the quantitative assessment of flow velocities. The difference MRI signal has a maximum value for opposite directions. This velocity is typically referred to as venc, and depends on the pulse amplitude and distance between the gradient pulse pair. For velocities larger than venc the difference signal is decreased constantly until it gets zero. Therefore, in a phase contrast angiography it is important to correctly set the venc of the sequence to the maximum flow velocity which is expected during the measurement. High venc factors of the PC angiogram (more than 40 cm/sec) will selectively image the arteries (PCA - arteriography), whereas a venc factor of 20 cm/sec will perform the veins and sinuses (PCV or MRV - venography).

See also Flow Quantification, Contrast Enhanced MR Venography, Time of Flight Angiography, Time Resolved Imaging of Contrast Kinetics.